|
1
|
Heindryckx F, Colle I and Van Vlierberghe
H: Experimental mouse models for hepatocellular carcinoma research.
Int J Exp Pathol. 90:367–386. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wei KR, Yu X, Zheng RS, Peng XB, Zhang SW,
Ji MF, Liang ZH, Ou ZX and Chen WQ: Incidence and mortality of
liver cancer in China, 2010. Chin J Cancer. 33:388–394.
2014.PubMed/NCBI
|
|
3
|
Yang CY, Chen YD, Guo W, Gao Y, Song CQ,
Zhang Q, Zheng NN, Han XJ and Guo CS: Bismuth ferrite-based
nanoplatform design: An ablation mechanism study of solid tumor and
NIR-triggered photothermal/photodynamic combination cancer therapy.
Adv Funct Mater. 17068272018. View Article : Google Scholar
|
|
4
|
Raza A and Sood GK: Hepatocellular
carcinoma review: Current treatment, and evidencebased medicine.
World J Gastroenterol. 20:4115–4127. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Abou-Alfa GK, Meyer T, Cheng AL,
El-Khoueiry AB, Rimassa L, Ryoo BY, Cicin I, Merle P, Park JW,
Blanc JF, et al: Cabozantinib (C) versus placebo (P) in patients
(pts) with advanced hepatocellular carcinoma (HCC) who have
received prior sorafenib: Results from the randomized phase III
CELESTIAL trial. J Clin Oncol. 36:2072018. View Article : Google Scholar
|
|
6
|
Bruix J, Qin S, Merle P, Granito A, Huang
YH, Bodoky G, Pracht M, Yokosuka O, Rosmorduc O, Breder V, et al:
Regorafenib for patients with hepatocellular carcinoma who
progressed on sorafenib treatment (RESORCE): A randomised,
double-blind, placebo-controlled, phase 3 trial. Lancet. 389:56–66.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kudo M, Finn RS, Qin S, Han KH, Ikeda K,
Piscaglia F, Baron A, Park JW, Han G, Jassem J, et al: Lenvatinib
versus sorafenib in frst-line treatment of patients with
unresectable hepatocellular carcinoma: A randomised phase 3
non-inferiority trial. Lancet. 391:1163–1173. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Puisieux A, Brabletz T and Caramel J:
Oncogenic roles of EMT-inducing transcription factors. Nat Cell
Biol. 16:488–494. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yopp AC and Singal AG: Epithelial to
mesenchymal transition expression profiles as predictive biomarkers
of recurrence following resection of HCC: Implications for current
clinical use and future stratification for systemic therapy. Ann
Surg Oncol. 21:3723–3724. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fransvea E, Angelotti U, Antonaci S and
Giannelli G: Blocking transforming growth factor-beta up-regulates
E-cadherin and reduces migration and invasion of hepatocellular
carcinoma cells. Hepatology. 47:1557–1566. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yamada S, Okumura N, Wei L, Fuchs BC,
Fujii T, Sugimoto H, Nomoto S, Takeda S, Tanabe KK and Kodera Y:
Epithelial to mesenchymal transition is associated with shorter
disease-free survival in hepatocellular carcinoma. Ann Surg Oncol.
21:3882–3890. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang CH, Guo ZY, Chen ZT, Zhi XT, Li DK,
Dong ZR, Chen ZQ, Hu SY and Li T: TMPRSS4 facilitates
epithelial-mesenchymal transition of hepatocellular carcinoma and
is a predictive marker for poor prognosis of patients after
curative resection. Sci Rep. 5:123662015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Boreddy SR, Pramanik KC and Srivastava SK:
Pancreatic tumor suppression by benzyl isothiocyanate is associated
with inhibition of PI3K/AKT/FOXO pathway. Clin Cancer Res.
17:1784–1795. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Aghazadeh S and Yazdanparast R:
Mycophenolic acid potentiates HER2-overexpressing SKBR3 breast
cancer cell line to induce apoptosis: Involvement of AKT/FOXO1 and
JAK2/STAT3 pathways. Apoptosis. 21:1302–1314. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dong T, Zhang Y, Chen Y, Liu P, An T,
Zhang J, Yang H, Zhu W and Yang X: FOXO1 inhibits the invasion and
metastasis of hepatocellular carcinoma by reversing ZEB2-induced
epithelial-mesenchymal transition. Oncotarget. 8:1703–1713.
2017.PubMed/NCBI
|
|
16
|
Zeng CX, Tang LY, Xie CY, Li FX, Zhao JY,
Jiang N, Tong Z, Fu SB, Wen FJ and Feng WS: Overexpression of
EPS8L3 promotes cell proliferation by inhibiting the transactivity
of FOXO1 in HCC. Neoplasma. 65:701–707. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kan H, Huang Y, Li X, Liu D, Chen J and
Shu M: Zinc finger protein ZBTB20 is an independent prognostic
marker and promotes tumor growth of human hepatocellular carcinoma
by repressing FoxO1. Oncotarget. 7:14336–14349. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu LT, Guo G, Wu M and Zhang WG: The
progress of the research on cardio-vascular effects and acting
mechanism of polydatin. Chin J Integr Med. 18:714–719. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gao JP, Chen CX, Gu WL, Wu Q, Wang Y and
Lü J: Effects of polydatin on attenuating ventricular remodeling in
isoproterenol-induced mouse and pressure-overload rat models.
Fitoterapia. 81:953–960. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shi YW, Wang CP, Liu L, Liu YL, Wang X,
Hong Y, Li Z and Kong LD: Antihyperuricemic and nephroprotective
effects of resveratrol and its analogues in hyperuricemic mice. Mol
Nutr Food Res. 56:1433–1444. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang Y, Zhuang Z, Meng Q, Jiao Y, Xu J
and Fan S: Polydatin inhibits growth of lung cancer cells by
inducing apoptosis and causing cell cycle arrest. Oncol Lett.
7:295–301. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
De Maria S, Scognamiglio I, Lombardi A,
Amodio N, Caraglia M, Cartenì M, Ravagnan G and Stiuso P:
Polydatin, a natural precursor of resveratrol, induces cell cycle
arrest and differentiation of human colorectal Caco-2 cell. J
Transl Med. 11:2642013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Redza-Dutordoir M and Averill-Bates DA:
Activation of apoptosis signalling pathways by reactive oxygen
species. Biochim Biophys Acta. 1863:2977–2992. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Larue L and Bellacosa A:
Epithelial-mesenchymal transition in development and cancer: Role
of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene.
24:7443–7454. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen YD, Zhang Y, Dong TX, Xu YT, Zhang W,
An TT, Liu PF and Yang XH: Hyperthermia with different temperatures
inhibits proliferation and promotes apoptosis through the
EGFR/STAT3 pathway in C6 rat glioma cells. Mol Med Rep.
16:9401–9408. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Luwor RB, Baradaran B, Taylor LE, Iaria J,
Nheu TV, Amiry N, Hovens CM, Wang B, Kaye AH and Zhu HJ: Targeting
Stat3 and Smad7 to restore TGF-β cytostatic regulation of tumor
cells in vitro and in vivo. Oncogene. 32:2433–2441. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang B, Zhang L and Zhao L, Zhou R, Ding
Y, Li G and Zhao L: LASP2 suppresses colorectal cancer progression
through JNK/p38 MAPK pathway meditated epithelial-mesenchymal
transition. Cell Commun Signal. 15:212017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hollman PC, de Vries JH, van Leeuwen SD,
Mengelers MJ and Katan MB: Absorption of dietary quercetin
glycosides and quercetin in healthy ileostomy volunteers. Am J Clin
Nutr. 62:1276–1282. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Paganga G and Rice-Evans CA: The
identifcation of flavonoids as glycosides in human plasma. FEBS
Lett. 401:78–82. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Krasnow MN and Murphy TM: Polyphenol
glucosylating activity in cell suspensions of grape (Vitis
vinifera). J Agric Food Chem. 52:3467–3472. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Delmas D, Aires V, Limagne E, Dutartre P,
Mazué F, Ghiringhelli F and Latruffe N: Transport, stability, and
biological activity of resveratrol. Ann N Y Acad Sci. 1215:48–59.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chalal M, Klinguer A, Echairi A, Meunier
P, Vervandier-Fasseur D and Adrian M: Antimicrobial activity of
resveratrol analogues. Molecules. 19:7679–7688. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tsai JH and Yang J: Epithelial-mesenchymal
plasticity in carcinoma metastasis. Genes Dev. 27:2192–2206. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mitra A, Mishra L and Li S: EMT, CTCs and
CSCs in tumor relapse and drug-resistance. Oncotarget.
6:10697–10711. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hsu CY, Lin CH, Jan YH, Su CY, Yao YC,
Cheng HC, Hsu TI, Wang PS, Su WP, Yang CJ, et al:
Huntingtin-interacting protein-1 is an early-stage prognostic
biomarker of lung adenocarcinoma and suppresses metastasis via
AKT-mediated epithelial-mesenchymal transition. Am J Respir Crit
Care Med. 193:869–880. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Attoub S, Arafat K, Hammadi NK, Mester J
and Gaben AM: AKT2 knock-down reveals its contribution to human
lung cancer cell proliferation, growth, motility, invasion and
endothelial cell tube formation. Sci Rep. 5:127592015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang Y, Liu S, Wang L, Wu Y, Hao J, Wang
Z, Lu W, Wang XA, Zhang F, Cao Y, et al: A novel PI3K/AKT signaling
axis mediates Nectin-4-induced gallbladder cancer cell
proliferation, metastasis and tumor growth. Cancer Lett.
375:179–189. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu J, Chang F, Li F, Fu H, Wang J, Zhang
S, Zhao J and Yin D: Palmitate promotes autophagy and apoptosis
through ROS-dependent JNK and p38 MAPK. Biochem Biophys Res Commun.
463:262–267. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ince S, Avdatek F, Demirel HH,
Arslan-Acaroz D, Goksel E and Kucukkurt I: Ameliorative effect of
polydatin on oxidative stress-mediated testicular damage by chronic
arsenic exposure in rats. Andrologia. 48:518–524. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ponugoti B, Dong G and Graves DT: Role of
forkhead transcription factors in diabetes-induced oxidative
stress, Exp. Diabetes Res. 2012:9397512012.
|
|
41
|
Du M, Wang Q, Li W, Ma X, Wu L, Guo F,
Zhao S, Huang F, Wang H and Qin G: Overexpression of FOXO1
ameliorates the podocyte epithelial-mesenchymal transition induced
by high glucose in vitro and in vivo. Biochem Biophys Res Commun.
471:416–422. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Duan S, Huang W, Liu X, Liu X, Chen N, Xu
Q, Hu Y, Song W and Zhou J: IMPDH2 promotes colorectal cancer
progression through activation of the PI3K/AKT/mTOR and
PI3K/AKT/FOXO1 signaling pathways. J Exp Clin Cancer Res.
37:3042017. View Article : Google Scholar
|
|
43
|
Jiang G and Huang C, Li J, Huang H, Jin H,
Zhu J, Wu XR and Huang C: Role of STAT3 and FOXO1 in the divergent
therapeutic responses of non-metastatic and metastatic bladder
cancer cells to miR-145. Mol Cancer Ther. 16:924–935. 2017.
View Article : Google Scholar : PubMed/NCBI
|
